Prognostic significance of the treadmill exercise test performance 6 months after myocardial infarction  by Stone, Peter H. et al.
lACC Vol. 8. No.5
November 1986:1007-17
COOPERATIVE STUDIES
Prognostic Significance of the Treadmill Exercise Test Performance
6 Months After Myocardial Infarction
PETER H. STONE, MD, FACC, ZOLTAN G. TURI, MD, FACC, JAMES E. MULLER, MD, FACC,
CORETTE PARKER, MSPH, TYLER HARTWELL, PHD, JOHN D. RUTHERFORD, MD, FACC,
ALLAN S. JAFFE, MD, FACC, DANIEL S. RAABE, MD, FACC,
EUGENE R. PASSAMANI, MD, FACC, JAMES T. WILLERSON, MD, FACC,
BURTON E. SOBEL, MD, FACC, THOMAS L. ROBERTSON, MD, FACC,
EUGENE BRAUNWALD, MD, FACC, AND THE MILlS STUDY GROUP*
Boston. Massachusetts
1007
A submaximal treadmill exercise test performed before
hospital discharge after an uncomplicated myocardial
infarction is often utilized to estimate prognosisand guide
management, but there is little experience with a max-
imal exercise test performed 6 months after infarction
to identify prognosis later in the convalescent period.
The performance characteristics during an exercise test
6 months after myocardial infarction were related to the
development of death, recurrent nonfatal myocardial
infarction and coronary artery bypass surgery in the
subsequent 12 months (that is, 6 to 18 months after
infarction) in 473 patients. Mortality was significantly
greater in patients who exhibited any of the following:
inability to perform the exercise test because of cardiac
limitations, the development of ST segment elevation of
1 mm or greater during the exercise test, an inadequate
blood pressure response during exercise, the develop-
ment of any ventricular premature depolarizations dur-
ing exercise or the recovery period and inability to ex-
ercise beyond stage I of the modified Bruce protocol. By
utilizing a combination of four high risk prognostic fea-
tures from the exercise test, it was possible to stratify
The treadmill exercise test performed before hospital dis-
charge after an uncomplicated myocardial infarction is widely
used to estimate prognosis and aid in management decisions
(1,2). Prognostic information can be gleaned from criteria
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patients in terms of risk of mortality, from 1% if none
of these features were present to 17% if three or four
were present.
Recurrent nonfatal myocardial infarction was pre-
dicted by an inability to perform the exercise test because
of cardiac limitations, but not by any characteristics of
exercise test performance. Coronary artery bypass sur-
gery was associated with the development of ST segment
depression of I mm or greater during the exercise test.
Although clinical evidence of angina and heart failure 6
months after infarction was predictive of subsequent
mortality among all survivors, among the low risk group
without severely limiting cardiac disease, the exercise
test provided unique prognostic information not avail-
able from clinical assessment alone. Therefore, a max-
imal exercise test performed 6 months after myocardial
infarction is a valuable, noninvasive tool to evaluate
prognosis. It provides information that is independent
of and additive to clinical evaluation performed at the
same time.
(1 Am Coli CardioI1986;8:1007-17)
including exertional ST segment depression or elevation
(3-12), exercise duration (13-16), blood pressure response
to exercise (16-18), the development of ventricular pre-
mature depolarizations (16) and the occurrence of angina
pectoris (16,19). Integration of information derived from
the predischarge exercise test with that derived from the
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patient's hospital course improves the assessment of prog-
nosis (3, 11,12,14,16,20). An exercise test is often repeated
6 to 8 weeks after the infarction when the myocardial scar
has presumably matured, using a maximal effort exercise
protocol to identify high risk patients (4,5,10,21,22).
However, the value of an exercise test performed later
in the convalescent phase (6 months or more) after infarction
is not clear. Although cardiac morbidity and mortality are
maximal in the first 6 months after infarction (23-27), iden-
tification of patients who remain at increased risk, 6 months
after the acute event would be useful. We therefore eval-
uated the relation between performance during an exercise
test 6 months after infarction and morbidity and mortality
during the following year. The prognostic value of the re-
sults of the test were compared with the prognostic value
of clinical characteristics at 6 months after infarction to
determine whether the test provided independent useful in-
formation .
Methods
Study group. The patients studied were a subgroup of
those enrolled in the Multicenter Investigation of the Lim-
itation of Infarct Size (MIllS), which was designed to de-
termine the effect of the administration of propranolol or
hyaluronidase on the size of acute myocardial infarction .
The MIllS protocol has been described previously (28) .
Patients were eligible for enrollment in MIllS if they were
younger than 76 years of age, had at least 30 minutes of
pain typical of myocardial ischemia and demonstrated
electrocardiographic criteria of acute myocardial ischemia
or evolving infarction (new Q waves greater than 30 ms in
width and 0.2 mV or greater in depth or ST segment ele-
vation or depression, or both, of 0.1 mV or greater in at
least two related leads), left bundle branch block or idio-
ventricular rhythm. Exclusion criteria, guidelines for stan-
dard care and procedures for the administration of hya-
luronidase or propranolol have been reported (28) .
As part of the MIllS protocol, all patients performed an
exercise test 6 months after myocardial infarction if they
were physically capable of performing the test and if they
and their physician consented. The test was incorporated
into the design of MIllS so that the long-term functional
consequences of pharmacologic interventions implemented
at the time of the index infarction could be assessed. Patients
were eligible for this data bank study only if myocardial
infarction had been confirmed and they survived for at least
6 months .
Data collection. Patients were evaluated 6 months after
infarction with a detailed interval history and physical ex-
amination and an exercise test performed according to a
modified Bruce protocol (29). The test was omitted if the
patient or the patient's physician did not provide consent or
if any of the following cardiac limitations were present:
reinfarction within the previous 3 months , unstable angina
or extremely limiting angina pectoris occurring more than
once daily despite medical treatment or severely limiting
the patient's activities, or both, New York Heart Association
class III or IV congestive heart failure (defined by history ,
a gallop rhythm and rales on chest examination), high grade
ventricular ectopic activity (2:6 ventricular premature po-
larizations per minute, couplets, ventricular tachycardia or
multifocal origin) and second or third degree atrioventricular
block. Patients were also excluded if they had a noncardiac
physical limitation such as an acute systemic illness or a
major musculoskeletal impairment.
Patients exercised on the treadmill until they were limited
by symptoms, developed a decrease in the systolic arterial
pressure of 10 mm Hg or greater, high grade ventricular
ectopic activity or conduction disturbances (as defined pre-
viously) or attained 90% or more of the maximal predicted
heart rate for age and maintained it for 1 minute. Target
heart rates were those recommended by the American Heart
Association (30). Twelve lead electrocardiograms recorded
during the test included tracings with the patient standing
and supine before exercise , at the end of each 3 minute
stage, immediately after completion of the exercise test and
2, 4, 6, 10 and 20 minutes during the recovery period or
until the ST segment deviation returned to baseline. The
entire set of electrocardiograms from each patient was sent
to a centralized ECG Core Laboratory, where all of the ST
segment interpretations were performed by one cardiologist
(P.H .S.). ST segment deviations were compared with the
PQ isoelectric line, and were recorded with reference to the
J point and 0.04 and 0.08 second after inscription of the J
point.
After the 6 month visit, the health status of all patients
was ascertained at 6 month intervals by telephone com-
munication. The date of death was recorded for patients
who died. Patients who developed a nonfatal recurrent in-
farction were identified, and the diagnosis was confirmed
by review of the hospitalization records.
End points. Mortality, the development of nonfatal re-
current infarction and the need for coronary artery bypass
surgery during the 12 months after the 6 month postinfarc-
tion visit were related to results of the exercise test to de-
termine risk. Inability to perform the test for either cardiac
or noncardiac reasons was evaluated as a potential prog-
nostic variable. Patients taking a beta-adrenergic blocking
agent at the time of the test were evaluated as a separate
group, as were those taking digoxin or those with baseline
features that could obscure the interpretation of the ST seg-
ment response to exercise, such as the presence of left ven-
tricular hypertrophy on the rest electrocardiogram. The ST
segment analysis was not performed in those patients with
left or right bundle branch block .
Prognosis was also compared with the clinical assess-
ment (history and physical examination) at the 6 month visit
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Table I. Reasons for Terminating Exercise Test in 473 Patients
*Total exceeds 100% because some patients discontinued exercise for
more than one reason. BP = blood pressure ; VPDs = ventricular pre-
mature depolarizations.
patients (28%) developed horizontal or downsloping ST seg-
ment depression of I mm or greater. Exertional ST segment
elevation of I mrn or greater occurred in 74 patients (17%),
of whom all but 2 exhibited a Q wave in the same or adjacent
lead on the rest electrocardiogram. During the test, 73 pa-
tients (15%) manifested an "inadequate blood pressure re-
sponse, " defined as an increase in systolic blood pressure
of less than I0 mm Hg from rest to peak exercise. A decrease
in systolic arterial pressure of 10 rnm Hg or more during
exercise occurred in 22 patients (5%) . Ventricular premature
depolarizations developed during exercise in 130 patients
(27%), and 48 of these patients developed frequent ven-
tricular premature depolarizations (> 6/min). One hundred
seventy patients (36%) were unable to complete stage [ (5
METS) of the modified Bruce protocol.
Clinical Outcome
In the year after performance of the exercise test (that
is, 6 to 18 months after infarction) 13 (3%) of the 473
patients died, 20 (5%) of the 440 patients who performed
the test and who had detailed follow-up data available de-
veloped a nonfatal recurrent infarction and 9 patients (2%)
underwent coronary artery bypass surgery. This low risk
group is in contrast to the 68 patients who could not perform
the test because of cardiac limitations. Among the latter
patients. II (16 %) died, and 8 (14%) of 59 developed a
nonfatal recurrent infarction (both differences p < 0.05
compared with those who performed the test) . Two patients
(3%) underwent coronary bypass surgery. Thus, the overall
results in the patients who did not perform the test because
of cardiac limitations were worse than those in the patients
who performed the test.
Among the 178 patients who did not perform the test
because of lack of consent, noncardiac physical limitations
or other miscellaneous reasons, 7 patients (4%) died, 12
(8%) of 151 patients developed a nonfatal recurrent infarc-
tion and 2 patients (I %) underwent coronary bypass surgery .
(%) *
(63)
(30 )
(14)
(6)
(3)
(3)
(I)
(I)
(3)
(7)
296
141
67
28
16
14
6
7
15
35
nReason
Fatigue
Shortne ss of breath
Angina
Claudication
Lightheadedness
Decrea se in systolic BP "" 10 mm Hg
Ventricular tachycardia or > 25% beats were VPDs
Peripheral circulatory insufficiency
Target heart rate achieved
Other
Results
to determine the potentially independent power of infor-
mation based on the exercise test.
Statistical analyses. Differences in the rates of mortal-
ity, recurrent nonfatal infarction and coronary artery bypass
surgery were assessed using chi-square tests and Fisher's
exact test where sample size was limited. Survival was
evaluated further with life table techniques, with generalized
Savage test statistics for those exercise test variables sig-
nificantly associated with mortality . Student's t tests were
used to test differences of means for variables of the con-
tinuous type.
Exercise Test Performance
No complications resulted from the exercise test. Exer-
cise was terminated for the reasons outlined in Table I . The
test performance characteristics and their prognostic signif-
icance are shown in Table 2. Ninety patients (20%) devel-
oped angina during the exercise, and in 44 (10%) of the
patients , the angina was accompanied by ST segment
depression of I mOl or greater. One hundred twenty-four
Clinical Characteristics
Among the 985 patients randomized to MIllS, 849 (86%)
developed a myocardial infarction, confirmed by the Crea-
tine Kinase Core Laboratory . Only those patients with a
confirmed infarction were included in this study . At the time
of the scheduled exercise test 6 months after infarction , 130
patients (15 %) had died and 719 patients (85%) remained
alive. Among the survivors , 473 (66%) performed the test
and 246 patients (34%) did not. Among the 473 patients
who performed the exercise test, the mean age was 54.8
years (range 20 to 75) and 374 patients (79%) were male.
Ninety-four patients (20%) had had an infarction before their
index infarction, and II patients (2%) had another infarction
between the time of the index infarction and the time of the
6 month follow-up visit. The index infarction was trans-
mural in 298 patients (63%), nontransmural in 133 patients
(28%) and could not be identified on the surface electro-
cardiogram (because of the presence of bundle branch block,
for example) in 42 patients (9%).
Among the 246 patients who did not perform the exercise
test. the reasons for not performing the test included lack
of consent (113 patients, 46%), cardiac limitations (68 pa-
tients, 28%), noncardiac physical limitations (46 patients,
19%) and other miscellaneous reasons (19 patients, 8%).
Among the 473 patients who performed the test, 122
patients (26%) had taken digoxin in the preceding 24 hours
and 185 patients (39%) had taken a beta-adrenergic blocking
agent in the same interval. Fifteen patients (3%) exhibited
left ventricular hypertrophy and 24 (5%) exhibited left or
right bundle branch block on the rest electrocardiogram.
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Cardiac inability to perform exercise test
Yes (n = 68)
No (n = 473)t
Tes t performance variable in those who performed test
Angina and/or ST depression ;0: I mm
Angina alone (n = 46)
ST depression alone (n = 80)
Angina and ST depression (n = 44)
No angina or ST depression (n = 278)
ST depression ;0: I mm
Yes (n = 124)
No (n = 324)
ST elevation ;0: I mm
Yes (n = 74)
No (n = 374)
Inadequate BP response
Yes (n = 73)
No (n = 399)
Decrease ;0: 10 mm Hg in systolic BP during exercise
Yes (n = 22)
No (n = 451 )
Exert ional VPDs
Yes (n = 130)
No (n = 343)
Inability to exercise beyond stage I
Yes (n = 170)
No (n = 303)
ST abnormal > 6 min of recovery
Yes (n = 77 )
No (n = 372)
Recurrent
Nonfatal MI§
Death (n = 24) (n = 28)
16%t 14%*
3% 5%
(n = 13) (n = 20)
2% 0%
1% 1%
2% 5%
3% 6%
2% 3%
3% 5%
8%t 4%
2% 4%
lO%t 6%
2% 4%
9% 5%
2% 5%
6%t 4%
1% 5%
6%t 2%*
1% 6%
5% 7%
2% 4%
*p < 0 .05; t p < 0 .0 1; tSome of the exercise test measurements could not be obtained from all 473 patients;
§Sample size was 440 of 473 for nonfatal recurrent myocardial infarction with adequate follow-up information.
MI = myocardial infarction; other abbreviation s as in Table 1. Values in parentheses are numbers of patients.
Thus, the overall results in this group were similar to those
in the patients who performed the test (p = NS).
Prognostic Value of Exercis e Test Performance
Mortality (Table 2, Fig . 1). Mortality after I year in
patients unable to perform the treadmill test 6 months after
infarction because of card iac limitations was significantly
higher than that in patients who performed the test (16 versus
3%, p < 0.01 ). Among patients who performed the test,
those who developed exercise-induced ST segment elevation
had a higher I year mortality rate than that of patients who
did not (8 versus 2%, p < 0.01 ) (Fig. 2). Failure to increase
systolic arterial pressure during the test was also associated
with a significantly higher mortality rate than that in those
who did raise arterial pressure (10 versus 2%, p < 0.0 1)
(Fig . 2). The poor prognosis associated with an inadequate
blood pressure response was most marked in patients who
were not taking a beta-adrenergic blocking agent at the time
of the test (18 versus 2% mortality rate, p < 0.01). De-
velopment of any ventricular premature depolarizations dur-
ing exercise was associated with an increased mortality rate
(6 versus 1%, p < 0.01) (Fig. 2). Frequent ventricular
premature depolarizations (> 6/min) were associated with
a higher mortality rate than that in patients without this
finding (8 versus 2%, p < 0.04).
Limited exercise capacity was associated with an in-
creased risk ofdeath in the subsequent year. Mean exercise
duration (± standard error) among the 13 patients who died
was 7.34 ± 0.96 versus 10.62 ± O.19 minutes for the 460
survivors (p < 0.01). Similarly, patients unable to exercise
beyond stage I of the modified Bruce protocol had a sig-
nificantly higher mortality rate than that of those able to
exercise to stage II (6 versus 1%, p < 0.0 1) (Fig. 2).
Mortality assessment based on a combination ofexercise
test variables. Categories of risk for mortality based on
combinations of individual prognostic variables identified
in this study (Table 2) are shown in Figure I, with equal
weight assigned to each of the four high risk features: in-
l ACC Vol. 8. No.5
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Figure 1. One year death rate after
health visit 6 months after myocardial
infarction. For patients who per-
formed the treadmill exercise test
(ETT), death rate is based on consid-
eration of the number of high risk fea-
tures observed. The high risk features
considered were an inadequate sys-
tolic blood pressure response, inability
to exercise beyond stage I of the mod-
ified Bruce protocol, development of
any ventricular premature depolari-
zations or exertional ST segment el-
evation during the test. The denomi-
nator for each bar indicates the number
of patients manifesting the number of
high risk features observed. The nu-
merator indicates the number of pa-
tients in the group who died. Of the
473 patients who performed the test,
447 were capable of exhibiting each
of the four high risk features, and 26
were capable of exhibiting only three
high risk features. Twenty-five pa-
tients were excluded from the ST seg-
ment analysis because of an uninter-
pretable ST segment (24 with left or
right bundle branch block and I with
technical failure of the electrocardio-
graph) and I patient could not have
his blood pressure determined during
exercise or in the recovery period.
adequate sys tolic blood pressure respon se , inability to ex-
ercise beyond stage I of the modified Bruce protocol , de-
velopment of any ventricular premature depolarizat ions or
exertional ST segment eleva tion of 1 mm or greater during
the test. The incidence rate of death in the year after the
test was only I% among the 178 patients who manifested
none of the four high risk performance fea tures, but in-
creased to 17% in the 30 patient s who manifested three or
four high risk features . (The number of patients (n = 3)
who exhibited all four risk features was too small to allow
statistica l analys is and these patients have therefore been
included with the group of patient s who exhibited three risk
features .) The 68 patients who were unable to perform the
treadmill test becau se of cardiac limitat ions manifested a 1
year mortality rate (16%) as high as that of the highest risk
stratum of patients who performed the test (Fig. 1), while
the 178 patient s who did not perform the test for rea sons
other than cardiac limitations had a mortal ity rate of
only 4%.
Recurrent nonfatal myocardial infarction (Table 2).
Of the total of 650 pati ent s, 40 (6%) developed a nonfatal
recurrent infarction 6 to 18 months after the inde x infarction .
Thi s group included 20 (5%) of 440 patients who perform ed
the test and 20 (10%) of 2 IO patients who did not. Among
the latter, recurrent nonfatal infarction occurred in 8 (14%)
of 59 patient s who did not perform the test because of cardiac
disability and in 12 (8%) of 151 patients who did not perform
the test for noncardiac reasons (p = NS). Thus , the inci -
dence of recurrent nonfatal infarction was significantly higher
among those patients who were unable to perform the ex-
ercise test because of cardiac limitations (14%) compared
with that among those who performed the test (5%) (p <
0.05).
Coronary artery bypass surgery. Among the 440 pa-
tient s who performed the test , 9 (2%) underwent coronary
bypass surgery in the subsequent yea r. The only exercise
test varia ble associated with bypass surgery was the devel-
opment of ST segment depression of I mm or grea ter during
the test. Six (5%) of the 116 pati ent s with exertional ST
segment depression underwent byp ass surgery compared
with 2 ( I%) of 301 patients who did not exhibit that vari able
(p < 0. 01 ). Coronary surgery was performed in 2 (3%) of
59 pat ients who did not perform the test because of cardiac
limitations and in 2 ( I%) of 151 pati ents who did not perform
the test for noncard iac rea sons (p = NS compared with the
patients who performed the test) .
Effect of beta-blocking agent Or digoxin use or rest
electrocardiographic abnormality at the time of the ex-
ercise test . There was no con sistent difference in the pre-
dictive value of the test performance features when the re-
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3). The MillS study group wa s analyzed first on the basis
of all patients available at 6 months after infarction (n =
698) to determ ine the prognostic value of the cl inical char-
acteri stics alone . Then the subgroup of patients who were
well enough and con sented to perform the treadmill test
(n = 473 ) was analyzed to determine whether these clin ical
features rem ained predicti ve of mortal ity in patients who
performed the test and whether the test provided progno stic
insight not ava ilable from clinical evaluation.
Prognostic value of heart failure and angina. Am ong
the entire group alive 6 months after infarction, the presence
of eith er heart failure or angina at the 6 month visit was
strongly associated with mortality in the subsequent 12
months. Of the 93 patients with a history of heart failure at
6 months , 14% died in the next 12 months, while only 3%
of the 582 patients without heart failure died (p < 0 .01 ).
Similarly , 8% of the 235 patients with angina at 6 months
died in the subsequent year, compared with onl y 3% of the
411 patient s without angina (p < 0.01 ). As might be an-
ticipated , the combined presence of angina and heart failure
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Figure 2. Cumulative probability of death in the 12 months after
the exercise test performed 6 months after infarction on the basis
of the observation of an inadequate systolic blood pressure (BP)
response, inability to exercise beyond Stage I of the modified Bruce
protocol, the development of ventricular premature depolarizations
(VPDs) or exertional ST segment elevation. The numberof patients
for the variable " inadequate blood pressure response" is 472 be-
cause blood pressure could not be determined in one patient. The
number of patients for the variable "exertional ST elevation" is
448 because the ST segment could not be interpreted in 25 patients
(24 with left or right bundle branch block and I with technical
failure of the electrocardiograph).
suits were analyzed separate ly on the basis of use of beta-
adrenergic blocking agents , although only one patient died
in the bet a-blocker group. There was no difference in the
predictive value of the ST segment response in the subgroup
of pat ient s not taking digoxin at the time of the test or in
those pati ents with left ventricular hypertroph y.
Prognostic Value of Clinical Versus Exercise Test
Performance Characteristics
To determine whether exerci se test performance variables
provided prognostic insight s beyond those obtained from
cl inical characteristics alone, we examined the prognostic
significance of the features from the history and physical
examination obtained at the time of the test 6 months after
infarction to predict the subsequent I year mortality (Table
Table 3. Comparison of Prognostic Significance of Clinical
Features in All Patients Versus Those Who Performed an
Exercise Test
Mortality
Clinical Featu re Amo ng All Ml Mortality Among MI
Noted at 6 Month Patient s Patients Who Performed
Visit (n = 698) Exercise Test (n = 473)
History of congestive
heart failure
Yes 13/93 (14%) 0/32 (0%)
No 20/582 (3%)t 13/429 (3%)
History of angina
Yes 18/235 (8% ) 41143 (3%)
No 12/41 1 (3% )t 81290 (3%)
History of MI in
addit ion to index
Ml
Yes 16/168 (10%) 5/103 (5%)
No 18/530 (3%) t 8/370 (2%)
Abnormal neck vein
distension
Yes 1/ 13 (8%) 0/5 (0%)
No 30/59 1 (5%) 13/461 (3%)
Pulmonary rales
Yes 9/43 (2 1%) 1/16 (6%)
No 22/563 (4%)t 12/451 (3%)
Presence of S,
Yes 4/3 1 (13%) 0/ 14 (0%)
No 27/545 (5%) 13/429 (3%)
Cardio mega ly on
ches t X-ray
Yes 9/5 1 (18%) 1/29 (3%)
No 8/ 117 (7%)* 5/9 1 (5%)
* p < 0.05: t p < 0.0 1. MI = myocard ial infarction; 5 , = third heart
sound.
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was a particularly poor prognostic sign. Nine (16%) of 58
patients with both conditions died, while the absence of
both conditions was associated with a low mortality (10
[3%] of 373 patients), Other manifestations of heart failure,
such as the presence of pulmonary rales on physical ex-
amination and cardiomegaly on chest X-ray study, were also
powerful predictors of mortality in this group of patients
after infarction (21% of 43 patients with rales and 18% of
51 patients with cardiomegaly at the 6 month visit died in
the next year, compared with only 4% of the 563 without
rales and only 7% of the 117 patients without cardiomegaly).
Clinical features versus ability to perform the exercise
test. Among the subgroup of patients who performed the
treadmill test 6 months after infarction, none of the clinical
features predicted mortality in the following year. In this
subgroup, none of the 32 patients who had heart failure at
6 months died compared with 3% of the 429 patients who
did not have heart failure (p = NS). Similarly, in this
subgroup of patients 3% of the 143 patients with angina at
6 months died as did 3% of the 290 patients without angina
(p = NS). Therefore, these clinical characteristics were
discriminatory only among the 205 patients who did not
perform the treadmill test. Among these, the mortality rate
was 2% (2 of 99 patients) in those without angina or heart
failure, 10% (5 of 50 patients) among those with angina but
not heart failure, 12% (2 of 17 patients) among those with
heart failure without angina and 23% (9 of 39 patients)
among those with both angina and heart failure. These dif-
ferences were also striking among the 63 patients who did
not perform the test because of cardiac disability. In this
group, the mortality rate was 8% (1 of 12 patients) among
those without angina or heart failure, 5% (1 of 20 patients)
among those with angina but not heart failure, 14% (1 of
7 patients) among those with heart failure but not angina
and 29% (7 of 24 patients) among those with both angina
and heart failure.
Hence, among all 6 month survirors of infarction, clin-
ical characteristics identified those at risk of death in the
subsequent 12 months. Among the low risk patients who
were well enough and consented to perform an exercise test
6 months after infarction, however, the exercise perform-
ance characteristics were much more powerful in estimating
prognosis than were clinical features obtained at the same
time in the convalescent phase.
Discussion
Use of exercise test after myocardial infarction. The
submaximal exercise test performed in the early convales-
cent phase (1 to 3 weeks) after an uncomplicated myocardial
infarction has been shown to be a safe and useful tool for
assessing prognosis (3-14,16,18,19-22,31). Combining the
submaximal exercise test with exercise radionuclide ven-
triculography or thallium-201 scintigraphy has proved even
more useful in predicting prognosis in the 6 months after
infarction (32-34). Because left ventricular function im-
proves gradually and then stabilizes over the ensuing months
(35) as the infarcted myocardium heals (36,37), a second
treadmill test is often performed 6 to 8 weeks after infarc-
tion, using a maximal exercise protocol, to stress the car-
diovascular system to its limits and thereby derive more
prognostic information (4,5,10,21,22), Exercise tolerance
increases progressively over at least 3 months (4,21), as
does maximally tolerated myocardial oxygen demand, as
reflected by systolic blood pressure and rate-pressure (dou-
ble) product. Although ischemic ST segment responses and
ventricular ectopic activity occur with comparable frequency
between 3 and 11 weeks after infarction (4,21), a maximal
exercise test performed 2 to 3 months after the acute event
elicits abnormal responses more often, and, therefore, more
prognostic information, than does the submaximal treadmill
test I to 3 weeks after infarction (22,30).
Prediction of mortality, recurrent nonfatal infarction
and coronary bypass surgery using the exercise test 6
months after infarction. There is limited experience con-
cerning the value of a maximal exercise test performed 6
months after myocardial infarction in predicting subsequent
morbidity and mortality. There have been many studies in
patients with previous infarction, however, that suggest that
the exercise test can identify the presence of multivessel
disease and poor left ventricular function, which are the
underlying determinants of subsequent morbidity and mor-
tality (38-42). The current study provides information on
a large group of patients who were observed prospectively
for I year after the 6 month postinfarction clinical evaluation
and exercise test. Our results indicate that the mortality
during the year after a 6 month exercise test is significantly
increased in patients who exhibit any of the following: in-
ability to perform the test because of cardiac limitations,
ST segment elevation of 1 mm or greater, an inadequate
blood pressure response during exercise, development of
any ventricular premature depolarizations during exercise
or the recovery period or inability to exercise beyond stage
I of the modified Bruce protocol. By utilizing a combination
of these high risk prognostic features, one can stratify pa-
tients in terms of risk of mortality. Patients who exhibited
none of the high risk features had a 1 year mortality rate of
only 1%, whereas patients who demonstrated more than one
characteristic experienced a mortality rate as high as 17%
(Fig. 1).
Results of most studies have shown that development of
ST segment depression during an exercise test performed
early in convalescence is associated with increased mortality
(3-11), although conclusions are not consistent (16,19,20).
Other variables such as exercise duration (13-16), inade-
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quate blood pressure increase with exercise (16-18), de-
velopment of angina (16,19), ST segment elevation (12),
ventricular ectopic activity (16) or inability to perform the
test because of cardiac limitations (10,16,18) may be more
powerful descriptors . Disparate conclu sions may reflect dif-
ferenc es in study design, sample size , exercise test proce-
dures or length of follow-up . Our observations indicate that
many of the exercise test performance characteristics that
are predictive of mortality in the early phase after infarction
remain predictive for those patient s who survive to the later
con valescent phase .
The prognostic power of the exercise performance vari-
ables observed in this study is underscored by the fact that
these variables predicted mortality in a group of patients
whose I year mortality rate was only 3%. The poor pre-
dictive value of exercise-induced angina or ST segment
depre ssion observed in this study may be due to the exclu-
sion of patients in whom myocardial ischemia is readily
provoked, such as those with angina that occur more than
once daily or severely limits activities. Among patients who
performed the test , the development of ST segment depres-
sion predicted those who subsequently underwent a coronary
bypas s procedure, and it is possible that identification of
these patients with jeopardized myocardium led to the sur-
gical or pharmacologic intervention that altered their prog-
nosis, thereby diluting the significance of that test variable .
However, becau se only 6 (5%) of the 116 patients who
exhibited ST segment depression underwent bypass surgery,
it is unlikely that the altered course of these few patients
exerted a major impact on the progno stic significance of the
ST segment depression variable. In fact, the exercise per-
formance features predictive of mortality in this study are
those most frequently associated with abnormal left ven-
tricular wall motion and impaired global function, namely,
exercise-induced ST segment elevation in the distribution
of transmural infarction (43), inadequate blood pressure re-
sponse to exercise and limited exercise tolerance. It is widely
recognized that the presence of left ventricular dysfunction
is an important marker for subsequent mortality (11,44).
The se findings are similar to those of Krone et al. (16), who
found that cardiac mortality was best related to pulmonary
congestion during the acute hospitalization and to a systolic
blood pressure of less than 110 mm Hg, angina and ven-
tricular couplets during a predischarge exercise test, wherea s
the need for coronary bypass surgery was best correlated
with ischemic ST segment depres sion or angina during the
test.
Recurrent nonfatal infarction was predicted only by in-
ability to perform the treadmill test because of cardiac lim-
itations. Recurrent episodes of infarction that could have
been predicted from results of the submaximal exercise test
performed I to 3 weeks after infarction may have already
occurred by the time the 6 month test was performed
(23 ,26,27). Thus, predischarge exercise test performance
features predictive of recurrent infarction, such as the de-
velopment of angina , ST segment depression, poor exercise
capacity, blunted arterial pressure increase with exercise or
the development of supraventricular ectopic depolarizations
(8,16,20), may lose their predictive significance when the
test is performed in the late convalescent period (~ 6 months
after infarction) . Furthermore, the mechanism of recurrent
nonfatal infarction in some patients may be attributable to
thrombosis (45), which would not necessarily be predictable
on the basis of exercise test results . Previous experience
with treadmill testing in the late convalescent phase to pre-
dict nonfatal cardiac events is limited (5,9,46).
Survivors of uncomplicated infarction are often treated
with a beta-adrenergic blocking agent (47-49). There were
too few deaths in this selected population to allow for ad-
equate assessment of the effect of beta-blocker use on the
value of the treadmill test in the prediction of mortality in
the subsequent year. Beta-blockers do not detract from the
prognostic value of an exercise test performed in early con-
valescence (3,7) .
Comparison of prognostic significance of clinical as-
sessment and exercise test performance. Our result s in-
dicate that clinical assessment utilizing history, physical
examination and chest X-ray study obtained 6 months after
infarction provides important prognostic information for the
total group of patients who survive infarction. Howe ver.
among the low risk patient s who were not severely limited
by angina or heart failure and who were capable of per-
forming an exercise test, these clinical variables were not
predictive of mortality. The maximal exercise test therefore
provides prognostic information not available from clinical
assessment alone in patient groups from which high risk
subjects have been excluded on clinical grounds. In the early
convalescent phase (1 to 6 weeks after infarction), the sub-
maximal exercise test has also been found to contribute
independently used prognostic information (3,9,11,12,14,16),
although some investigators (50) have observed that clinical
assessment and ST segment depres sion on the predischarge
rest electrocardiogram predict prognosis more accurately
than do variables derived from the exercise test.
Clinical implications. Our results suggest that the ex-
ercise test performed 6 months after acute myocardial in-
farction provides progno stic information not available from
clinical assessments alone. A submaximal exercise test per-
formed before hospital discharge after myocardial infarction
is standard practice. A maximal effort treadmill test 6 months
after infarction may help to identify those survivors without
clinical complications who remain at particularly high risk
in the subsequent 12 months .
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